{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:50:33Z","timestamp":1782874233098,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16080-5","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:46:46Z","timestamp":1778233606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel Chimeric Antigen Receptor (CAR) - strategy to target EGFRVIII-mutated glioblastoma cells via macrophages"],"prefix":"10.1186","volume":"26","author":[{"given":"Kristi","family":"Vera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclen","family":"Esken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Wook","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Chaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noufissa","family":"Oudrhiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Desterke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Bennaceur-Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"16080_CR1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nrc.2016.97","volume":"16","author":"AD Fesnak","year":"2016","unstructured":"Fesnak AD, June CH, Levine BL, Engineered T. Cells: The Promise and Challenges of Cancer Immunotherapy. Nat Rev Cancer. 2016;16:566\u201381.","journal-title":"Nat Rev Cancer"},{"key":"16080_CR2","doi-asserted-by":"publisher","first-page":"1113882","DOI":"10.3389\/fimmu.2023.1113882","volume":"14","author":"A Daei Sorkhabi","year":"2023","unstructured":"Daei Sorkhabi A, Mohamed Khosroshahi L, Sarkesh A, Mardi A, Aghebati-Maleki A, Aghebati-Maleki L, Baradaran B. The Current Landscape of CAR T-Cell Therapy for Solid Tumors: Mechanisms, Research Progress, Challenges, and Counterstrategies. Front Immunol. 2023;14:1113882.","journal-title":"Front Immunol"},{"key":"16080_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11912-023-01380-x","volume":"25","author":"G Guzman","year":"2023","unstructured":"Guzman G, Reed MR, Bielamowicz K, Koss B, Rodriguez A. CAR-T Therapies in Solid Tumors: Opportunities and Challenges. Curr Oncol Rep. 2023;25:479\u201389.","journal-title":"Curr Oncol Rep"},{"key":"16080_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky M, Ruella M, Shestova O, Lu XM, Best A, Zeeman M, Schmierer M, Gabrusiewicz K, Anderson NR, Petty NE, et al. Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy. Nat Biotechnol. 2020;38:947\u201353.","journal-title":"Nat Biotechnol"},{"key":"16080_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","volume":"25","author":"A Lei","year":"2024","unstructured":"Lei A, Yu H, Lu S, Lu H, Ding X, Tan T, Zhang H, Zhu M, Tian L, Wang X, et al. A Second-Generation M1-Polarized CAR Macrophage with Antitumor Efficacy. Nat Immunol. 2024;25:102\u201316.","journal-title":"Nat Immunol"},{"key":"16080_CR6","doi-asserted-by":"crossref","unstructured":"Morrissey MA, Williamson AP, Steinbach AM, Roberts EW, Kern N, Headley MB, Vale RD. Chimeric Antigen Receptors That Trigger Phagocytosis. eLife. 2018;7:e36688.","DOI":"10.7554\/eLife.36688"},{"key":"16080_CR7","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/cancers13051123","volume":"13","author":"JL Mangal","year":"2021","unstructured":"Mangal JL, Handlos JL, Esrafili A, Inamdar S, Mcmillian S, Wankhede M, Gottardi R, Acharya AP. Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies. Cancers. 2021;13:1123.","journal-title":"Cancers"},{"key":"16080_CR8","doi-asserted-by":"publisher","first-page":"1615760","DOI":"10.3389\/fimmu.2025.1615760","volume":"16","author":"A Morva","year":"2025","unstructured":"Morva A, Arroyo AB, Andreeva L, Tapia-Abell\u00e1n A, Luengo-Gil G. Unleashing the Power of CAR-M Therapy in Solid Tumors: A Comprehensive Review. Front Immunol. 2025;16:1615760.","journal-title":"Front Immunol"},{"key":"16080_CR9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","volume":"31","author":"KA Reiss","year":"2025","unstructured":"Reiss KA, Angelos MG, Dees EC, Yuan Y, Ueno NT, Pohlmann PR, Johnson ML, Chao J, Shestova O, Serody JS, et al. CAR-Macrophage Therapy for HER2-Overexpressing Advanced Solid Tumors: A Phase 1 Trial. Nat Med. 2025;31:1171\u201382.","journal-title":"Nat Med"},{"key":"16080_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/ph13100273","volume":"13","author":"C O\u2019Leary","year":"2020","unstructured":"O\u2019Leary C, Gasper H, Sahin KB, Tang M, Kulasinghe A, Adams MN, Richard DJ, O\u2019Byrne KJ. Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC). Pharmaceuticals. 2020;13:273.","journal-title":"Pharmaceuticals"},{"key":"16080_CR11","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.3390\/ijms26083539","volume":"26","author":"F Zhu","year":"2025","unstructured":"Zhu F, Qiu J, Ye H, Su W, Wang R, Fu Y. The Prognostic Significance of Epidermal Growth Factor Receptor Amplification and Epidermal Growth Factor Receptor Variant III Mutation in Glioblastoma: A Systematic Review and Meta-Analysis with Implications for Targeted Therapy. Int J Mol Sci. 2025;26:3539.","journal-title":"Int J Mol Sci"},{"key":"16080_CR12","doi-asserted-by":"publisher","first-page":"669103","DOI":"10.3389\/fimmu.2021.669103","volume":"12","author":"W Fu","year":"2021","unstructured":"Fu W, Lei C, Ma Z, Qian K, Li T, Zhao J, Hu S. CAR Macrophages for SARS-CoV-2 Immunotherapy. Front Immunol. 2021;12:669103.","journal-title":"Front Immunol"},{"key":"16080_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: Ultrafast Universal RNA-Seq Aligner. Bioinforma Oxf Engl. 2013;29:15\u201321.","journal-title":"Bioinforma Oxf Engl"},{"key":"16080_CR14","doi-asserted-by":"publisher","first-page":"D493","DOI":"10.1093\/nar\/gkh103","volume":"32","author":"D Karolchik","year":"2004","unstructured":"Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, Kent WJ. The UCSC Table Browser Data Retrieval Tool. Nucleic Acids Res. 2004;32:D493\u2013496.","journal-title":"Nucleic Acids Res"},{"key":"16080_CR15","doi-asserted-by":"publisher","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","volume":"50","author":"F Cunningham","year":"2022","unstructured":"Cunningham F, Allen JE, Allen J, Alvarez-Jarreta J, Amode MR, Armean IM, Austine-Orimoloye O, Azov AG, Barnes I, Bennett R, et al. Ensembl 2022. Nucleic Acids Res. 2022;50:D988\u201395.","journal-title":"Nucleic Acids Res"},{"key":"16080_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK, edgeR. A Bioconductor Package for Differential Expression Analysis of Digital Gene Expression Data. Bioinforma Oxf Engl. 2010;26:139\u201340.","journal-title":"Bioinforma Oxf Engl"},{"key":"16080_CR17","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. Voom: Precision Weights Unlock Linear Model Analysis Tools for RNA-Seq Read Counts. Genome Biol. 2014;15:R29.","journal-title":"Genome Biol"},{"key":"16080_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"16080_CR19","doi-asserted-by":"publisher","first-page":"15534","DOI":"10.1038\/s41598-020-72664-6","volume":"10","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Wong L, Goh WWB. How to Do Quantile Normalization Correctly for Gene Expression Data Analyses. Sci Rep. 2020;10:15534.","journal-title":"Sci Rep"},{"key":"16080_CR20","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. clusterProfiler 4.0: A Universal Enrichment Tool for Interpreting Omics Data. Innov. 2021;2:100141.","journal-title":"Innov"},{"key":"16080_CR21","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, Tang W, Wang Q, Liu B, Wang R, et al. Using clusterProfiler to Characterize Multiomics Data. Nat Protoc. 2024;19:3292\u2013320.","journal-title":"Nat Protoc"},{"key":"16080_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene Ontology: Tool for the Unification of Biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"16080_CR23","doi-asserted-by":"publisher","first-page":"D331","DOI":"10.1093\/nar\/gkw1108","volume":"45","author":"The Gene Ontology Consortium Expansion of the Gene","year":"2017","unstructured":"The Gene Ontology Consortium Expansion of the Gene. Ontology Knowledgebase and Resources. Nucleic Acids Res. 2017;45:D331\u20138.","journal-title":"Nucleic Acids Res"},{"key":"16080_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. Integrative Genomics Viewer. Nat Biotechnol. 2011;29:24\u20136.","journal-title":"Nat Biotechnol"},{"key":"16080_CR25","doi-asserted-by":"publisher","first-page":"1675807","DOI":"10.3389\/fimmu.2025.1675807","volume":"16","author":"Y Hou","year":"2025","unstructured":"Hou Y, Hu S, Liu C, Chen X, Wang Y, Li Y, Fu Z, Feng C, Gong Y, Liu Z, et al. Beyond CAR-T Cells: Exploring CAR-NK, CAR-M, and CAR-\u0393\u03b4 T Strategies in Solid Tumor Immunotherapy. Front Immunol. 2025;16:1675807.","journal-title":"Front Immunol"},{"key":"16080_CR26","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage Polarization States in the Tumor Microenvironment. Int J Mol Sci. 2021;22:6995.","journal-title":"Int J Mol Sci"},{"key":"16080_CR27","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12967-023-04479-8","volume":"21","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhu X, Liu H, Wang C, Chen Y, Wang H, Fang Y, Wu X, Xu Y, Li C, et al. The Application of HER2 and CD47 CAR-Macrophage in Ovarian Cancer. J Transl Med. 2023;21:654.","journal-title":"J Transl Med"},{"key":"16080_CR28","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1111\/febs.12393","volume":"280","author":"HK Gan","year":"2013","unstructured":"Gan HK, Cvrljevic AN, Johns TG. The Epidermal Growth Factor Receptor Variant III (EGFRvIII): Where Wild Things Are Altered. FEBS J. 2013;280:5350\u201370.","journal-title":"FEBS J"},{"key":"16080_CR29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41467-024-55770-1","volume":"16","author":"S Pierini","year":"2025","unstructured":"Pierini S, Gabbasov R, Oliveira-Nunes MC, Qureshi R, Worth A, Huang S, Nagar K, Griffin C, Lian L, Yashiro-Ohtani Y, et al. Chimeric Antigen Receptor Macrophages (CAR-M) Sensitize HER2\u2009+\u2009Solid Tumors to PD1 Blockade in Pre-Clinical Models. Nat Commun. 2025;16:706.","journal-title":"Nat Commun"},{"key":"16080_CR30","doi-asserted-by":"publisher","first-page":"1464218","DOI":"10.3389\/fcell.2024.1464218","volume":"12","author":"T Huang","year":"2024","unstructured":"Huang T, Bei C, Hu Z, Li Y. CAR-Macrophage: Breaking New Ground in Cellular Immunotherapy. Front Cell Dev Biol. 2024;12:1464218.","journal-title":"Front Cell Dev Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16080-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16080-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16080-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:41:23Z","timestamp":1782873683000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16080-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16080"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16080-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for the publication of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"792"}}